Main InformationTargeteIF5A/eIF5A2Host SpeciesRabbitReactivityHuman, Mouse, RatApplicationsWB, ELISAMW17kD (Observed)Conjugate/ModificationUnmodifiedDetailed InformationRecommended Dilution RatioWB 1:500-2000; ELISA(peptide)1:5000-20000FormulationLiquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.SpecificityThis antibody detects endogenous levels of human eIF5A/eIF5A2PurificationThe antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.Storage-15°C to -25°C/1 year(Do not lower than -25°C)Concentration1 mg/mlMW(Observed)17kDModificationUnmodifiedClonalityPolyclonalIsotypeIgGAntigen&Target InformationImmunogen:Synthesized peptide derived from human eIF5A/eIF5A2Specificity:This antibody detects endogenous levels of human eIF5A/eIF5A2Gene Name:EIF5AProtein Name:eIF5A/eIF5A2Other Name:Eukaryotic translation initiation factor 5A-1 ; eIF-5A-1 ; eIF-5A1 ; Eukaryotic initiation factor 5A isoform 1 ; eIF-5A ; Rev-binding factor ; eIF-4D ;Function:Function:The precise role of eIF-5A in protein biosynthesis is not known but it functions by promoting the formation of the first peptide bond.,PTM:eIF-5A seems to be the only eukaryotic protein to have an hypusine residue which is a post-translational modification of a lysine by the addition of a butylamino group (from spermidine).,similarity:Belongs to the eIF-5A family.,subunit:Found in a complex with Ran and XPO4. The hypusine modification increases the interaction with XPO4.,tissue specificity:Expressed in umbilical vein endothelial cells and several cancer cell lines (at protein level).,Cellular Localization:Cytoplasm . Nucleus . Endoplasmic reticulum membrane ; Peripheral membrane protein ; Cytoplasmic side . Hypusine modification promotes the nuclear export and cytoplasmic localization and there was a dynamic shift in the localization from predominantly cytoplasmic to primarily nuclear under apoptotic inducing conditions (PubMed:19379712, PubMed:27306458). Nuclear export of hypusinated protein is mediated by XPO4 (PubMed:10944119, PubMed:27306458). .Tissue Expression:Expressed in umbilical vein endothelial cells and several cancer cell lines (at protein level).